DKP Critical Insights® Syndicated Reports
DKP has developed a series of syndicated reports to provide perspectives into the oncology and rare-disease environment. The reports are designed to help you inform short- and long-term strategies that will support market positioning of your portfolio, as well as ongoing patient access to care.
Medicaid PBM Influence on Oncology
Click here for more information
- Identify key PBM relationships with Fee-for-Service Medicaid agencies
- Outline the role and influence of key PBMs illustrating where they may impact new drug coverage and positioning, prior authorization development, drug purchasing pool oversight, and supplemental rebate solicitation